<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0">
    <channel>
        <title><![CDATA[Sovereign - Mushrooms Legislation]]></title>
        <description><![CDATA[Latest mushrooms bills tracked across all 50 US states]]></description>
        <link>https://www.thesir.app/industry/mushrooms/</link>
        <generator>RSS for Node</generator>
        <lastBuildDate>Thu, 30 Apr 2026 14:56:43 GMT</lastBuildDate>
        <atom:link href="https://www.thesir.app/feed/mushrooms.xml" rel="self" type="application/rss+xml"/>
        <copyright><![CDATA[2026 Sovereign Industry Report]]></copyright>
        <language><![CDATA[en]]></language>
        <item>
            <title><![CDATA[[IA] HF978: A bill for an act relating to the production and administration of psilocybin, and providing penalties. (Formerly HF 620.)]]></title>
            <description><![CDATA[A bill for an act relating to the production and administration of psilocybin, and providing penalties. (Formerly HF 620.)]]></description>
            <link>https://www.thesir.app/bill/IA-HF978/</link>
            <guid isPermaLink="false">https://www.thesir.app/bill/IA-HF978/</guid>
            <pubDate>Tue, 21 Apr 2026 00:00:00 GMT</pubDate>
        </item>
        <item>
            <title><![CDATA[[IA] SF2151: A bill for an act removing psilocybin and psilocyn from the list of substances classified as schedule I controlled substances under Iowa's uniform controlled substances Act.]]></title>
            <description><![CDATA[A bill for an act removing psilocybin and psilocyn from the list of substances classified as schedule I controlled substances under Iowa's uniform controlled substances Act.]]></description>
            <link>https://www.thesir.app/bill/IA-SF2151/</link>
            <guid isPermaLink="false">https://www.thesir.app/bill/IA-SF2151/</guid>
            <pubDate>Tue, 21 Apr 2026 00:00:00 GMT</pubDate>
        </item>
        <item>
            <title><![CDATA[[IA] HF2085: A bill for an act relating to the production and administration of psilocybin and providing penalties.]]></title>
            <description><![CDATA[A bill for an act relating to the production and administration of psilocybin and providing penalties.]]></description>
            <link>https://www.thesir.app/bill/IA-HF2085/</link>
            <guid isPermaLink="false">https://www.thesir.app/bill/IA-HF2085/</guid>
            <pubDate>Tue, 21 Apr 2026 00:00:00 GMT</pubDate>
        </item>
        <item>
            <title><![CDATA[[MD] SB336: Task Force on Responsible Use of Natural Psychedelic Substances - Extension and Membership]]></title>
            <description><![CDATA[Extending to December 31, 2027, the Task Force on Responsible Use of Natural Psychedelic Substances to study and make recommendations related to the use of natural psychedelic substances; adding a representative of a historically Black college or university in the State to the Task Force; and requiring the Task Force to submit an updated report of its findings and recommendations to the Governor and the General Assembly on or before October 31, 2026.]]></description>
            <link>https://www.thesir.app/bill/MD-SB336/</link>
            <guid isPermaLink="false">https://www.thesir.app/bill/MD-SB336/</guid>
            <pubDate>Mon, 13 Apr 2026 00:00:00 GMT</pubDate>
        </item>
        <item>
            <title><![CDATA[[MD] HB427: Task Force on Responsible Use of Natural Psychedelic Substances - Extension]]></title>
            <description><![CDATA[Extending to December 31, 2027, the Task Force on Responsible Use of Natural Psychedelic Substances to study and make recommendations related to the use of natural psychedelic substances; and requiring the Task Force to submit an updated report of its findings and recommendations to the Governor and the General Assembly on or before October 31, 2026.]]></description>
            <link>https://www.thesir.app/bill/MD-HB427/</link>
            <guid isPermaLink="false">https://www.thesir.app/bill/MD-HB427/</guid>
            <pubDate>Mon, 13 Apr 2026 00:00:00 GMT</pubDate>
        </item>
        <item>
            <title><![CDATA[[KS] HB2218: Amending the definition of "psilocybin" in the uniform controlled substances act to exclude the pharmaceutical composition of crystalline polymorph psilocybin and adding crystalline polymorph psilocybin to schedule IV of the uniformed controlled substance act.]]></title>
            <description><![CDATA[Amending the definition of "psilocybin" in the uniform controlled substances act to exclude the pharmaceutical composition of crystalline polymorph psilocybin and adding crystalline polymorph psilocybin to schedule IV of the uniformed controlled substance act.]]></description>
            <link>https://www.thesir.app/bill/KS-HB2218/</link>
            <guid isPermaLink="false">https://www.thesir.app/bill/KS-HB2218/</guid>
            <pubDate>Fri, 10 Apr 2026 00:00:00 GMT</pubDate>
        </item>
        <item>
            <title><![CDATA[[GA] HB382: Controlled substances; Schedule I; psilocybin; revise a provision]]></title>
            <description><![CDATA[A BILL to be entitled an Act to amend Code Section 16-13-25 of the Official Code of Georgia Annotated, relating to Schedule I controlled substances, so as to revise a provision relating to psilocybin; to provide for related matters; to repeal conflicting laws; and for other purposes.]]></description>
            <link>https://www.thesir.app/bill/GA-HB382/</link>
            <guid isPermaLink="false">https://www.thesir.app/bill/GA-HB382/</guid>
            <pubDate>Mon, 06 Apr 2026 00:00:00 GMT</pubDate>
        </item>
        <item>
            <title><![CDATA[[GA] HB717: Medical Practice Act; regulation of the administration of psychedelic-assisted treatment and therapy; provide]]></title>
            <description><![CDATA[A BILL to be entitled an Act to amend Article 2 of Chapter 34 of Title 43 of the Official Code of Georgia Annotated, relating to the "Medical Practice Act of the State of Georgia," so as to provide for the regulation of the administration of psychedelic-assisted treatment and therapy; to provide for definitions; to provide for standards; to provide for requirements; to provide for the establishment of rules and regulations; to provide for licensure of clinics; to provide for statutory construction; to provide for related matters; to repeal conflicting laws; and for other purposes.]]></description>
            <link>https://www.thesir.app/bill/GA-HB717/</link>
            <guid isPermaLink="false">https://www.thesir.app/bill/GA-HB717/</guid>
            <pubDate>Mon, 06 Apr 2026 00:00:00 GMT</pubDate>
        </item>
        <item>
            <title><![CDATA[[MS] SB2056: Controlled substances; provide for automatic scheduling of certain substance if federal scheduling occurs.]]></title>
            <description><![CDATA[An Act To Automatically Schedule, On The State Schedules Of Controlled Substances, Any Pharmaceutical Composition Crystalline Polymorph Psilocybin That Is Approved By The United States Food And Drug Administration And Scheduled By The United States Drug Enforcement Administration; To Provide That The Automatic Scheduling Shall Be Effective For A Certain Time Period; To Amend Section 41-29-111, Mississippi Code Of 1972, To Delete Outdated Language Related To Covid-19; And For Related Purposes.]]></description>
            <link>https://www.thesir.app/bill/MS-SB2056/</link>
            <guid isPermaLink="false">https://www.thesir.app/bill/MS-SB2056/</guid>
            <pubDate>Sun, 05 Apr 2026 00:00:00 GMT</pubDate>
        </item>
        <item>
            <title><![CDATA[[MA] H4050: To amend the General Laws, in relation to promoting the health and well-being of the residents of the Commonwealth of Massachusetts by establishing a comprehensive framework supporting public health and safety through regulated adult use, support services, and cultivation of psilocybin-containing fungi; and providing for taxation and appropriation thereof]]></title>
            <description><![CDATA[Relative to adult use, support services, cultivation and taxation of psilocybin-containing fungi. Revenue.]]></description>
            <link>https://www.thesir.app/bill/MA-H4050/</link>
            <guid isPermaLink="false">https://www.thesir.app/bill/MA-H4050/</guid>
            <pubDate>Thu, 02 Apr 2026 00:00:00 GMT</pubDate>
        </item>
        <item>
            <title><![CDATA[[MO] HB1717: Modifies provisions relating to alternative therapies and treatments, including psilocybin]]></title>
            <description><![CDATA[Modifies provisions relating to alternative therapies and treatments, including psilocybin]]></description>
            <link>https://www.thesir.app/bill/MO-HB1717/</link>
            <guid isPermaLink="false">https://www.thesir.app/bill/MO-HB1717/</guid>
            <pubDate>Thu, 02 Apr 2026 00:00:00 GMT</pubDate>
        </item>
        <item>
            <title><![CDATA[[LA] SB43: Provides relative to psychedelic-assisted therapy. (8/1/26) (OR +$110,433 GF EX See Note)]]></title>
            <description><![CDATA[Provides relative to psychedelic-assisted therapy. (8/1/26) (OR +$110,433 GF EX See Note)]]></description>
            <link>https://www.thesir.app/bill/LA-SB43/</link>
            <guid isPermaLink="false">https://www.thesir.app/bill/LA-SB43/</guid>
            <pubDate>Mon, 30 Mar 2026 00:00:00 GMT</pubDate>
        </item>
        <item>
            <title><![CDATA[[SD] HB1099: Reschedule the pharmaceutical composition of crystalline polymorph psilocybin in a drug product approved by the Food and Drug Administration as a Schedule IV controlled substance.]]></title>
            <description><![CDATA[Reschedule the pharmaceutical composition of crystalline polymorph psilocybin in a drug product approved by the Food and Drug Administration as a Schedule IV controlled substance.]]></description>
            <link>https://www.thesir.app/bill/SD-HB1099/</link>
            <guid isPermaLink="false">https://www.thesir.app/bill/SD-HB1099/</guid>
            <pubDate>Mon, 30 Mar 2026 00:00:00 GMT</pubDate>
        </item>
        <item>
            <title><![CDATA[[IL] SB2772: PSILOCYBIN ADVISORY BOARD]]></title>
            <description><![CDATA[Creates the Illinois Psilocybin Advisory Board Act. Sets forth findings and defines terms. Establishes the Illinois Psilocybin Advisory Board within the Department of Financial and Professional Regulation for the purpose of advising and making recommendations to the Department regarding the provision of psilocybin and psilocybin services. Sets forth requirements for members of the Board. Provides that, within 3 months after the effective date of the Act, the Governor, the Senate President, the Speaker of the House, the Minority Leader of the House, and the Minority Leader of the Senate shall appoint certain individuals to the Board. Provides that, between January 1, 2027 and January 1, 2029, the Board shall meet at least once every 2 calendar months at a time and place determined by the chairperson or a majority of the voting members of the Board and that, after January 1, 2029, the Board shall meet at least once every calendar quarter. Provides that the Board shall perform certain duties, including publishing an annual report describing the Board's activities and making recommendations concerning (i) the safety and efficacy of psilocybin and other substances, (ii) potential requirements for providing psilocybin services to clients, (iii) a potential code of ethics and possible training requirements for facilitators, and (iv) public health considerations. Makes other changes. Effective immediately.]]></description>
            <link>https://www.thesir.app/bill/IL-SB2772/</link>
            <guid isPermaLink="false">https://www.thesir.app/bill/IL-SB2772/</guid>
            <pubDate>Fri, 27 Mar 2026 00:00:00 GMT</pubDate>
        </item>
        <item>
            <title><![CDATA[[IL] SB2184: USE AND RESEARCH-ENTHEOGENS]]></title>
            <description><![CDATA[Creates the Compassionate Use and Research of Entheogens Act. Establishes the Illinois Psilocybin Advisory Board within the Department of Financial and Professional Regulation for the purpose of advising and making recommendations to the Department regarding the provision of psilocybin and psilocybin services. Provides that the Department shall begin receiving applications for the licensing of persons to manufacture or test psilocybin products, operate service centers, or facilitate psilocybin services. Contains licensure requirements and prohibitions. Provides that a licensee or licensee representative may manufacture, deliver, or possess a psilocybin product. Provides that a licensee or licensee representative may not sell or deliver a psilocybin product to a person under 21 years of age. Provides that a person may not sell, give, or otherwise make available a psilocybin product to a person who is visibly intoxicated. Creates the Psilocybin Control and Regulation Fund and the Illinois Psilocybin Fund and makes conforming changes in the State Finance Act. Requires the Department of Agriculture, the Department of Financial and Professional Regulation, and the Department of Revenue to perform specified duties. Contains provisions concerning rulemaking, taxes, fees, zoning, labeling, and penalties. Provides that beginning January 1, 2026, a tax is imposed upon purchasers for the privilege of using psilocybin at a rate of 15% of the purchase price. Preempts home rule powers. Contains other provisions. Amends the Illinois Vehicle Code. Provides that a person shall not drive or be in actual physical control of any vehicle within the State while there is any amount of a drug, substance, or compound in the person's breath, blood, other bodily substance, or urine resulting from the unlawful use or consumption of psilocybin as defined in the Compassionate Use and Research of Entheogens Act. Amends the Illinois Controlled Substances Act. Removes psilocybin and psilocin from the list of Schedule I controlled substances. Amends the Illinois Independent Tax Tribunal Act of 2012. Provides that the Tax Tribunal shall have original jurisdiction over all determinations of the Department of Revenue reflected on specified notices issued under the Compassionate Use and Research of Entheogens Act. Amends the Freedom of Information Act to exempt specific records from disclosure. Effective immediately.]]></description>
            <link>https://www.thesir.app/bill/IL-SB2184/</link>
            <guid isPermaLink="false">https://www.thesir.app/bill/IL-SB2184/</guid>
            <pubDate>Fri, 27 Mar 2026 00:00:00 GMT</pubDate>
        </item>
        <item>
            <title><![CDATA[[IL] HB1143: ILLINOIS CURE ACT]]></title>
            <description><![CDATA[Creates the Compassionate Use and Research of Entheogens Act. Establishes the Illinois Psilocybin Advisory Board. Provides a timeline for the Board. Provides that the Department of Public Health, the Department of Agriculture, the Department of Financial and Professional Regulation, the Illinois State Police, and the Department of Revenue may adopt rules and implement the Act. Provides for licensing to operate a service center, facilitate psilocybin services, manufacture psilocybin products, and test psilocybin products by certain State agencies, with certain requirements. Provides for the lawful manufacture, delivery, and possession of psilocybin products. Provides procedures for psilocybin services, including requirements for certain sessions, plans, and forms. Limits the sale of psilocybin products with certain restrictions. Provides for investigations and inspections under the Act. Provides for certain fees, fines, actions against a licensee, criminal penalties, and civil penalties for violations of the Act. Provides for administrative hearings and other requirements for disciplining an applicant or licensee. Provides requirements for psilocybin-producing fungi as a crop, food, or other commodity. Provides for labeling and packaging requirements. Imposes a tax on psilocybin. Establishes the Psilocybin Control and Regulation Fund and Illinois Psilocybin Fund as special funds in the State treasury. Limits home rule powers. Makes other provisions. Makes corresponding changes to the State Finance Act. Amends the Freedom of Information Act. Exempt certain correspondence and records under the Act. Amends the Illinois Independent Tax Tribunal Act of 2012. Adds the Act to the jurisdiction of the Tax Tribunal. Amends the Illinois Vehicle Code. Adds psilocybin or psilocin to the list of prohibited substances for a person driving or in actual physical control of a vehicle. Amends the Illinois Controlled Substances Act. Removes psilocybin or psilocybin products from the definition of "Controlled Substance". Removes psilocybin and psilocyn from the list of Schedule I controlled substances. Effective immediately.]]></description>
            <link>https://www.thesir.app/bill/IL-HB1143/</link>
            <guid isPermaLink="false">https://www.thesir.app/bill/IL-HB1143/</guid>
            <pubDate>Fri, 27 Mar 2026 00:00:00 GMT</pubDate>
        </item>
        <item>
            <title><![CDATA[[IL] HB2992: HOPE PILOT PROGRAM]]></title>
            <description><![CDATA[Creates the Healing Opportunities through Psilocybin Equity Pilot Program Act. Details findings, purposes, statutory construction, and definitions. Establishes the Illinois Psilocybin Advisory Board within the Department of Financial and Professional Regulation. Provides duties of the Board. Provides that the Department of Public Health, the Department of Agriculture, the Department of Financial and Professional Regulation, the Illinois State Police, and the Department of Revenue have certain duties, functions, and powers under the Act. Provides for a program development period, with certain requirements. Provides for different types of licenses starting on or before July 1 of the year 3 years after the effective date of the Act, with certain requirements. Provides immunity from certain criminal civil liability for a licensee or licensee representative with respect to manufacture, delivery, and possession of psilocybin products. Provides requirements for psilocybin services. Provides for discipline of licensees. Provides for civil and criminal penalties for violations. Provides for certain administrative hearings. Limits home rule. Imposes a tax upon purchasers for the privilege of using psilocybin at a rate of 15% of the purchase price. Establishes the Psilocybin Control and Regulation Fund and the Illinois Psilocybin Fund as special funds in the State Treasury for certain purposes. Makes other provisions. Amends the Freedom of Information Act to exempt certain information under the Healing Opportunities through Psilocybin Equity Pilot Program Act from disclosure. Amends the State Finance Act and the Illinois Independent Tax Tribunal Act of 2012 to make conforming changes. Amends the Illinois Vehicle Code to add psilocybin or psilocin as defined in the Healing Opportunities Through Psilocybin Equity Pilot Program Act to provisions regarding driving while under the influence. Effective immediately.]]></description>
            <link>https://www.thesir.app/bill/IL-HB2992/</link>
            <guid isPermaLink="false">https://www.thesir.app/bill/IL-HB2992/</guid>
            <pubDate>Fri, 27 Mar 2026 00:00:00 GMT</pubDate>
        </item>
        <item>
            <title><![CDATA[[MA] H1858: Relative to removing criminal penalties for limited psilocybin possession]]></title>
            <description><![CDATA[Relative to removing criminal penalties for limited psilocybin possession. The Judiciary.]]></description>
            <link>https://www.thesir.app/bill/MA-H1858/</link>
            <guid isPermaLink="false">https://www.thesir.app/bill/MA-H1858/</guid>
            <pubDate>Thu, 26 Mar 2026 00:00:00 GMT</pubDate>
        </item>
        <item>
            <title><![CDATA[[MA] H1624: Establishing a task force to study equitable access to psilocybin and other entheogenic plants]]></title>
            <description><![CDATA[For legislation to establish an interagency task force to study the public health and social justice implications of legalizing the possession, consumption, transportation, and distribution of naturally cultivated entheogenic plants and fungi. The Judiciary.]]></description>
            <link>https://www.thesir.app/bill/MA-H1624/</link>
            <guid isPermaLink="false">https://www.thesir.app/bill/MA-H1624/</guid>
            <pubDate>Thu, 26 Mar 2026 00:00:00 GMT</pubDate>
        </item>
        <item>
            <title><![CDATA[[MA] H1726: Relative to criminal disposition of limited psilocybin possession offenses]]></title>
            <description><![CDATA[Relative to criminal disposition of limited psilocybin possession offenses. The Judiciary.]]></description>
            <link>https://www.thesir.app/bill/MA-H1726/</link>
            <guid isPermaLink="false">https://www.thesir.app/bill/MA-H1726/</guid>
            <pubDate>Thu, 26 Mar 2026 00:00:00 GMT</pubDate>
        </item>
        <item>
            <title><![CDATA[[MA] H2203: Establishing a pilot program for access to regulated psilocybin]]></title>
            <description><![CDATA[For legislation to authorize the Department of Public Health to establish a pilot program for psilocybin services for adults with post-traumatic stress disorder and other specified conditions. Mental Health, Substance Use and Recovery.]]></description>
            <link>https://www.thesir.app/bill/MA-H2203/</link>
            <guid isPermaLink="false">https://www.thesir.app/bill/MA-H2203/</guid>
            <pubDate>Mon, 23 Mar 2026 00:00:00 GMT</pubDate>
        </item>
        <item>
            <title><![CDATA[[MN] HF4577: Psilocybin therapeutic use program established; protections for registered patients, registered suppliers, registered facilitators, and health care practitioners established; civil actions authorized; advisory committee established; and money appropriated.]]></title>
            <description><![CDATA[Psilocybin therapeutic use program established; protections for registered patients, registered suppliers, registered facilitators, and health care practitioners established; civil actions authorized; advisory committee established; and money appropriated.]]></description>
            <link>https://www.thesir.app/bill/MN-HF4577/</link>
            <guid isPermaLink="false">https://www.thesir.app/bill/MN-HF4577/</guid>
            <pubDate>Mon, 23 Mar 2026 00:00:00 GMT</pubDate>
        </item>
        <item>
            <title><![CDATA[[MN] SF4485: Psilocybin therapeutic use program establishment]]></title>
            <description><![CDATA[Psilocybin therapeutic use program establishment]]></description>
            <link>https://www.thesir.app/bill/MN-SF4485/</link>
            <guid isPermaLink="false">https://www.thesir.app/bill/MN-SF4485/</guid>
            <pubDate>Tue, 17 Mar 2026 00:00:00 GMT</pubDate>
        </item>
        <item>
            <title><![CDATA[[CT] SB191: An Act Concerning The Psychedelic-assisted Therapy Pilot Program.]]></title>
            <description><![CDATA[To expand access to and extend the psychedelic-assisted therapy pilot program.]]></description>
            <link>https://www.thesir.app/bill/CT-SB191/</link>
            <guid isPermaLink="false">https://www.thesir.app/bill/CT-SB191/</guid>
            <pubDate>Mon, 16 Mar 2026 00:00:00 GMT</pubDate>
        </item>
        <item>
            <title><![CDATA[[MN] HF2906: Psilocybin therapeutic use program established; protections for registered patients, designated cultivators, registered facilitators, and health care practitioners established; rulemaking authorized; civil actions authorized; fees established; advisory committee established; criminal penalties provided; and money appropriated.]]></title>
            <description><![CDATA[Psilocybin therapeutic use program established; protections for registered patients, designated cultivators, registered facilitators, and health care practitioners established; rulemaking authorized; civil actions authorized; fees established; advisory committee established; criminal penalties provided; and money appropriated.]]></description>
            <link>https://www.thesir.app/bill/MN-HF2906/</link>
            <guid isPermaLink="false">https://www.thesir.app/bill/MN-HF2906/</guid>
            <pubDate>Mon, 16 Mar 2026 00:00:00 GMT</pubDate>
        </item>
        <item>
            <title><![CDATA[[IN] HB1191: Decriminalization of marijuana.]]></title>
            <description><![CDATA[[FAVORABLE] Decriminalization of marijuana. Decriminalizes possession of two ounces or less of marijuana.]]></description>
            <link>https://www.thesir.app/bill/IN-HB1191/</link>
            <guid isPermaLink="false">https://www.thesir.app/bill/IN-HB1191/</guid>
            <pubDate>Sat, 14 Mar 2026 00:00:00 GMT</pubDate>
        </item>
        <item>
            <title><![CDATA[[VA] SB379: Psilocybin; Board of Pharmacy to reschedule upon federal scheduling changes.]]></title>
            <description><![CDATA[Board of Pharmacy; regulation of psilocybin. Directs the Board of Pharmacy to reschedule psilocybin consistent with federal scheduling upon approval by the U.S. Food and Drug Administration of a formulation of psilocybin designed to be administered by a health care professional in a health care setting. This bill is identical to HB 1347.]]></description>
            <link>https://www.thesir.app/bill/VA-SB379/</link>
            <guid isPermaLink="false">https://www.thesir.app/bill/VA-SB379/</guid>
            <pubDate>Sat, 14 Mar 2026 00:00:00 GMT</pubDate>
        </item>
        <item>
            <title><![CDATA[[VA] HB1347: Psilocybin; Board of Pharmacy to reschedule upon federal scheduling changes.]]></title>
            <description><![CDATA[Board of Pharmacy; regulation of psilocybin. Directs the Board of Pharmacy to reschedule psilocybin consistent with federal scheduling upon approval by the U.S. Food and Drug Administration of a formulation of psilocybin designed to be administered by a health care professional in a health care setting. This bill is identical to SB 379.]]></description>
            <link>https://www.thesir.app/bill/VA-HB1347/</link>
            <guid isPermaLink="false">https://www.thesir.app/bill/VA-HB1347/</guid>
            <pubDate>Sat, 14 Mar 2026 00:00:00 GMT</pubDate>
        </item>
        <item>
            <title><![CDATA[[WV] SB906: Permitting lawful prescription of crystalline polymorph psilocybin under FDA recommendations]]></title>
            <description><![CDATA[The purpose of this bill is to permit lawful prescription, distribution, and marketing of any composition of crystalline polymorph psilocybin that the United States Food and Drug Administration approves and that is rescheduled by the United States Drug Enforcement Administration, in accordance with the recommendations of the United States Food and Drug Administration.]]></description>
            <link>https://www.thesir.app/bill/WV-SB906/</link>
            <guid isPermaLink="false">https://www.thesir.app/bill/WV-SB906/</guid>
            <pubDate>Sat, 14 Mar 2026 00:00:00 GMT</pubDate>
        </item>
        <item>
            <title><![CDATA[[WV] HB5588: Establish a regulated framework for the medical use of psilocybin to treat post-traumatic stress disorder (PTSD)]]></title>
            <description><![CDATA[The purpose of this bill is to adopt the Therapeutic Psilocybin Act.]]></description>
            <link>https://www.thesir.app/bill/WV-HB5588/</link>
            <guid isPermaLink="false">https://www.thesir.app/bill/WV-HB5588/</guid>
            <pubDate>Sat, 14 Mar 2026 00:00:00 GMT</pubDate>
        </item>
        <item>
            <title><![CDATA[[WV] HB4640: Relating to drugs and adding a provision relating to the scheduling of crystalline polymorph psilocybin approved by the Food and Drug Administration]]></title>
            <description><![CDATA[The purpose of this bill is to add crystalline polymorph psilocybin in the permitted list of distributed and prescribed drugs, if approved by the United States Food and Drug Administration and scheduled by the United States Drug Enforcement Administration.]]></description>
            <link>https://www.thesir.app/bill/WV-HB4640/</link>
            <guid isPermaLink="false">https://www.thesir.app/bill/WV-HB4640/</guid>
            <pubDate>Sat, 14 Mar 2026 00:00:00 GMT</pubDate>
        </item>
        <item>
            <title><![CDATA[[WV] HB4721: Relating to drugs and adding a provision relating to the scheduling of crystalline polymorph psilocybin approved by the Food and Drug Administration]]></title>
            <description><![CDATA[The purpose of this bill is to add a provision in Schedule I drugs relating to the scheduling of crystalline polymorph psilocybin, if approved by the Food and Drug Administration and the Drug Enforcement Administration, and declare that will be lawful to prescribe, distribute and market this drug.]]></description>
            <link>https://www.thesir.app/bill/WV-HB4721/</link>
            <guid isPermaLink="false">https://www.thesir.app/bill/WV-HB4721/</guid>
            <pubDate>Sat, 14 Mar 2026 00:00:00 GMT</pubDate>
        </item>
        <item>
            <title><![CDATA[[FL] HB1100: Functional Mushroom Product Regulation]]></title>
            <description><![CDATA[Regulates functional mushroom and adaptogenic mushroom supplements. Sets mushroom labeling and mushroom safety standards for products containing lion's mane, reishi, and chaga extracts.]]></description>
            <link>https://www.thesir.app/bill/FL-HB1100/</link>
            <guid isPermaLink="false">https://www.thesir.app/bill/FL-HB1100/</guid>
            <pubDate>Fri, 13 Mar 2026 00:00:00 GMT</pubDate>
        </item>
        <item>
            <title><![CDATA[[WA] SB5921: Concerning psilocybin.]]></title>
            <description><![CDATA[Concerning psilocybin.]]></description>
            <link>https://www.thesir.app/bill/WA-SB5921/</link>
            <guid isPermaLink="false">https://www.thesir.app/bill/WA-SB5921/</guid>
            <pubDate>Thu, 12 Mar 2026 00:00:00 GMT</pubDate>
        </item>
        <item>
            <title><![CDATA[[WA] SB5201: Concerning access to psychedelic substances.]]></title>
            <description><![CDATA[Concerning access to psychedelic substances.]]></description>
            <link>https://www.thesir.app/bill/WA-SB5201/</link>
            <guid isPermaLink="false">https://www.thesir.app/bill/WA-SB5201/</guid>
            <pubDate>Thu, 12 Mar 2026 00:00:00 GMT</pubDate>
        </item>
        <item>
            <title><![CDATA[[WA] HB1433: Concerning access to psychedelic substances.]]></title>
            <description><![CDATA[Concerning access to psychedelic substances.]]></description>
            <link>https://www.thesir.app/bill/WA-HB1433/</link>
            <guid isPermaLink="false">https://www.thesir.app/bill/WA-HB1433/</guid>
            <pubDate>Thu, 12 Mar 2026 00:00:00 GMT</pubDate>
        </item>
        <item>
            <title><![CDATA[[MN] SF3971: Psilocybin therapeutic use program establishment]]></title>
            <description><![CDATA[Psilocybin therapeutic use program establishment]]></description>
            <link>https://www.thesir.app/bill/MN-SF3971/</link>
            <guid isPermaLink="false">https://www.thesir.app/bill/MN-SF3971/</guid>
            <pubDate>Wed, 11 Mar 2026 00:00:00 GMT</pubDate>
        </item>
        <item>
            <title><![CDATA[[MS] HB563: Controlled substances; provide for automatic scheduling of psilocybin after federal scheduling.]]></title>
            <description><![CDATA[An Act To Amend Section 41-29-111, Mississippi Code Of 1972, To Provide For Automatic State Scheduling Of Psilocybin After Federal Scheduling; To Bring Forward Sections 41-29-113 Through 41-29-121, Mississippi Code Of 1972, Which Relate To The Uniform Controlled Substances Law, For Purposes Of Possible Amendment; And For Related Purposes.]]></description>
            <link>https://www.thesir.app/bill/MS-HB563/</link>
            <guid isPermaLink="false">https://www.thesir.app/bill/MS-HB563/</guid>
            <pubDate>Wed, 11 Mar 2026 00:00:00 GMT</pubDate>
        </item>
        <item>
            <title><![CDATA[[MN] SF4204: Psilocybin regulation provisions]]></title>
            <description><![CDATA[Psilocybin regulation provisions]]></description>
            <link>https://www.thesir.app/bill/MN-SF4204/</link>
            <guid isPermaLink="false">https://www.thesir.app/bill/MN-SF4204/</guid>
            <pubDate>Mon, 09 Mar 2026 00:00:00 GMT</pubDate>
        </item>
        <item>
            <title><![CDATA[[NH] HB1809: Authorizing the medical use of psilocybin through a program established in the department of health and human services.]]></title>
            <description><![CDATA[Authorizing the medical use of psilocybin through a program established in the department of health and human services.]]></description>
            <link>https://www.thesir.app/bill/NH-HB1809/</link>
            <guid isPermaLink="false">https://www.thesir.app/bill/NH-HB1809/</guid>
            <pubDate>Mon, 09 Mar 2026 00:00:00 GMT</pubDate>
        </item>
        <item>
            <title><![CDATA[[OR] HB4040: Relating to health care; declaring an emergency.]]></title>
            <description><![CDATA[Modifies the requirements for screening a hospital patient for presumptive eligibility for financial assistance. [<i>Prohibits the Oregon Health Authority from requiring certain home health agencies to comply with Medicare conditions of participation.</i>] [<i>Modifies the requirements for how the Department of Human Services must publish Residential Care Quality Measurement Program data.</i>] Removes the requirement that an applicant for a residential care facility administrator license hold a bachelor's degree in a health or social service related field. Allows a person residing in a correctional facility to receive prerelease medical assistance benefits under certain circumstances. [<i>Prohibits the authority or a coordinated care organization from requiring prior authorization for medical assistance coverage for repairing complex rehabilitation technology if the repair costs $1,500 or less.</i>] Modifies the requirements for meetings held by the Health Evidence Review Commission. Modifies the composition of the Medicaid Advisory Committee. Modifies the eligibility requirements for parent providers who are paid to provide attendant care services to their children. [<i>Prohibits a coordinated care organization or dental subcontractor from preventing an oral health care provider from informing consumers about their choice of providers.</i>] Allows a full-time dentistry student enrolled in an out-of-state dental education program to practice dentistry without a license if the student is supervised by a faculty member of a dental education program accredited by the Commission on Dental Accreditation of the American Dental Association. Requires casualty or health insurance policies to provide coverage for medically necessary anesthesia services, regardless of duration, for any covered procedures. Requires dental insurers to follow certain rules for payment and denial of claims. Requires the Legislative Policy and Research Director to develop and propose to the [<i>Legislative Policy and Research Committee</i>] <b>committees with jurisdiction over health care</b> an insurance coverage mandate impact statement policy. Directs the [<i>committee</i>] <b>committees</b> to perform due diligence in considering the proposal and authorizes the [<i>committee</i>] <b>committees</b> to modify the proposal if the [<i>committee</i>] <b>committees</b> so [<i>determines</i>]<b> determine</b>, and then to adopt the policy. Repeals requirement that enrollees in individual or group policies or certificates of health insurance [<i>or members of coordinated care organizations</i>] be assigned by <b>their</b> insurer [<i>or organization</i>] to primary care providers under certain circumstances. Specifies exemptions from the requirement that pharmacy services administrative organizations must register with the Department of Consumer and Business Services as third party administrators. [<i>Provides that the Governor shall select the chairperson of the Prescription Drug Affordability Board.</i>]<b> <b>Modifies requirements for the Prescription Drug Affordability Board's annual affordability determination for insulin products.</b> Allows licensees of the Occupational Therapy Licensing Board and the Oregon Board of Physical Therapy to provide psilocybin services as licensed psilocybin service facilitators while providing occupational therapy or physical therapy services. [Authorizes a <i>naturopathic physician to prescribe durable medical equipment and admit a patient to a hospital</i>.]. Declares an emergency, effective on passage.]]></description>
            <link>https://www.thesir.app/bill/OR-HB4040/</link>
            <guid isPermaLink="false">https://www.thesir.app/bill/OR-HB4040/</guid>
            <pubDate>Mon, 09 Mar 2026 00:00:00 GMT</pubDate>
        </item>
        <item>
            <title><![CDATA[[RI] H7925: Amends current law on controlled substances to permit psilocybin to be cultivated within a person's residence for personal use and contingent on the Food and Drug Administration (FDA) program, mandates that RI DOH establishes rules regulations.]]></title>
            <description><![CDATA[FOOD AND DRUGS -- UNIFORM CONTROLLED SUBSTANCES ACT - Amends current law on controlled substances to permit psilocybin to be cultivated within a person's residence for personal use and contingent on the Food and Drug Administration (FDA) program, mandates that RI DOH establishes rules regulations.]]></description>
            <link>https://www.thesir.app/bill/RI-H7925/</link>
            <guid isPermaLink="false">https://www.thesir.app/bill/RI-H7925/</guid>
            <pubDate>Fri, 27 Feb 2026 00:00:00 GMT</pubDate>
        </item>
        <item>
            <title><![CDATA[[MO] HB1643: Modifies provisions relating to alternative therapies and treatments, including psilocybin]]></title>
            <description><![CDATA[Modifies provisions relating to alternative therapies and treatments, including psilocybin]]></description>
            <link>https://www.thesir.app/bill/MO-HB1643/</link>
            <guid isPermaLink="false">https://www.thesir.app/bill/MO-HB1643/</guid>
            <pubDate>Thu, 26 Feb 2026 00:00:00 GMT</pubDate>
        </item>
        <item>
            <title><![CDATA[[MO] SB1767: Modifies provisions relating to alternative therapies and treatments, including psilocybin]]></title>
            <description><![CDATA[Modifies provisions relating to alternative therapies and treatments, including psilocybin]]></description>
            <link>https://www.thesir.app/bill/MO-SB1767/</link>
            <guid isPermaLink="false">https://www.thesir.app/bill/MO-SB1767/</guid>
            <pubDate>Thu, 26 Feb 2026 00:00:00 GMT</pubDate>
        </item>
        <item>
            <title><![CDATA[[MO] SB1682: Modifies provisions relating to alternative therapies and treatments, including psilocybin]]></title>
            <description><![CDATA[Modifies provisions relating to alternative therapies and treatments, including psilocybin]]></description>
            <link>https://www.thesir.app/bill/MO-SB1682/</link>
            <guid isPermaLink="false">https://www.thesir.app/bill/MO-SB1682/</guid>
            <pubDate>Thu, 19 Feb 2026 00:00:00 GMT</pubDate>
        </item>
        <item>
            <title><![CDATA[[NM] HB336: Use Of Fda-approved Psilocybin]]></title>
            <description><![CDATA[Use Of Fda-approved Psilocybin]]></description>
            <link>https://www.thesir.app/bill/NM-HB336/</link>
            <guid isPermaLink="false">https://www.thesir.app/bill/NM-HB336/</guid>
            <pubDate>Thu, 19 Feb 2026 00:00:00 GMT</pubDate>
        </item>
        <item>
            <title><![CDATA[[CO] HB26-1050: Natural Medicine Psilocybin Facilitator Program]]></title>
            <description><![CDATA[Implements the natural medicine program for psilocybin and psilocin. Establishes psychedelic facilitator licensing, guided psychedelic session requirements, and psychedelic service center regulations.]]></description>
            <link>https://www.thesir.app/bill/CO-HB26-1050/</link>
            <guid isPermaLink="false">https://www.thesir.app/bill/CO-HB26-1050/</guid>
            <pubDate>Sun, 15 Feb 2026 00:00:00 GMT</pubDate>
        </item>
        <item>
            <title><![CDATA[[NY] S3200: Entheogenic Plant Medicine Decriminalization Act]]></title>
            <description><![CDATA[[FAVORABLE] Decriminalizes possession and use of entheogenic plants including psilocybin mushrooms. Establishes natural plant medicine research program.]]></description>
            <link>https://www.thesir.app/bill/NY-S3200/</link>
            <guid isPermaLink="false">https://www.thesir.app/bill/NY-S3200/</guid>
            <pubDate>Thu, 12 Feb 2026 00:00:00 GMT</pubDate>
        </item>
        <item>
            <title><![CDATA[[RI] HB7756: AN ACT RELATING TO FOOD AND DRUGS -- UNIFORM CONTROLLED SUBSTANCES ACT]]></title>
            <description><![CDATA[Amends current law on controlled substances to permit psilocybin to be cultivated within a person's residence for personal use and contingent on the US FDA's program, mandate that RI department of health establish rules regulations.]]></description>
            <link>https://www.thesir.app/bill/RI-HB7756/</link>
            <guid isPermaLink="false">https://www.thesir.app/bill/RI-HB7756/</guid>
            <pubDate>Thu, 12 Feb 2026 00:00:00 GMT</pubDate>
        </item>
        <item>
            <title><![CDATA[[RI] H7756: Amends current law on controlled substances to permit psilocybin to be cultivated within a person's residence for personal use and contingent on the US FDA's program, mandate that RI department of health establish rules regulations.]]></title>
            <description><![CDATA[FOOD AND DRUGS -- UNIFORM CONTROLLED SUBSTANCES ACT - Amends current law on controlled substances to permit psilocybin to be cultivated within a person's residence for personal use and contingent on the US FDA's program, mandate that RI department of health establish rules regulations.]]></description>
            <link>https://www.thesir.app/bill/RI-H7756/</link>
            <guid isPermaLink="false">https://www.thesir.app/bill/RI-H7756/</guid>
            <pubDate>Thu, 12 Feb 2026 00:00:00 GMT</pubDate>
        </item>
    </channel>
</rss>